Corrected: BRIEF-Theratechnologies Q1 Revenue USD 19.05 Million
09/04/2025 12:30
Apr 09 (Reuters) - Theratechnologies Q1 adjusted EBITDA USD 2.321 million. Q1 net income USD 229 thousand outlook FY revenue USD 80-83 million
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process